Eidos

Eidos Therapeutics is a biopharmaceutical company that develops a novel oral therapy to treat transthyretin amyloidosis.

Business Model:

Revenue: $26.7M

Employees: 11-50

Detailed Eidos Information

Eidos was acquired by BridgeBio Pharma.
The acquisition happend on 2020-10-05.
Details of the transaction were not public

Acquirer

Geographic Data

Eidos headquarters map

Address: 101 Montgomery Street

City: San Francisco

State: CA

Zip: 94101

Country: US

Financial Info

Stage:

series b

Raised Last:

$64M

Raised Total:

$64M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Eidos Therapeutics is a biopharmaceutical company that develops a novel oral therapy to treat transthyretin amyloidosis.

Contact Phone:
+14158871471

Contact Email:

Eidos went public on 6/20/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
6/20/2018

IPO Valuation:
$608M

Ticker Symbol:
EIDX

IPO Price:
$17/share

Amount Raised:
$106M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research